Congress trades
Genmab A/S (GMAB)
About Genmab A/S
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Jan van de Winkel
- Employees
- 3,119
- Listed since
- Jun 1, 2009
- Market value
- $20.3B
- Price to earnings
- 25.3
- Earnings per share
- $1.29
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | $0.54 | $0.37 | $1.2B | $1.1B | EPS beatRevenue beat |
| Q1 FY2026reported May 7, 2026 | $0.09 | $0.15 | $896.0M | $905.8M | EPS missRevenue in line |
| Q4 FY2025reported Feb 17, 2026 | $0.05 | $0.46 | $1.1B | $1.1B | EPS missRevenue in line |
| Q3 FY2025reported Nov 6, 2025 | $0.65 | $0.48 | $1.0B | $1.0B | EPS beatRevenue in line |
| Q2 FY2025reported Aug 7, 2025 | $0.54 | $0.39 | $924.8M | $952.6M | EPS beatRevenue miss |
| Q1 FY2025reported May 8, 2025 | $0.31 | $0.23 | $726.0M | $755.5M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | $360.8M | 13,133,131 | +64.8% | 2.14% |
| Orbis Allan Gray Ltd | $312.3M | 11,368,161 | -12.0% | 1.85% |
| Alliancebernstein L.P. | $231.9M | 8,644,877 | -9.5% | 1.41% |
| Deerfield Management Company, L.P. (Series C) | $188.6M | 6,865,000 | +178.8% | 1.12% |
| DEEP Track Capital, LP | $155.2M | 5,650,000 | +54.2% | 0.92% |
| Arrowstreet Capital, Limited Partnership | $136.7M | 4,975,324 | 0.0% | 0.81% |
| Blackrock, Inc. | $128.3M | 4,671,252 | +3.0% | 0.76% |
| Sofinnova Investments, Inc. | $111.1M | 4,045,215 | +437.7% | 0.66% |
| Renaissance Technologies LLC | $96.6M | 3,517,850 | -20.3% | 0.57% |
| Two Sigma Investments, LP | $96.3M | 3,506,843 | +49.9% | 0.57% |
| Harding Loevner LP | $86.9M | 3,086,318 | -4.5% | 0.50% |
| DEEP Track Capital, LP | $82.4M | 3,000,000 | +100.0% | 0.49% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in GMAB
11 disclosures of 11 on record · median 29d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +27.9%S&P +20.7% · vs S&P 500 +7.3% | Mar 30, 2026 | Jul 21, 2026 | 113d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +55.7%S&P +28.8% · vs S&P 500 +26.9% | Jan 16, 2025 | Feb 10, 2025 | 25d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +65.0%S&P +25.7% · vs S&P 500 +39.4% | Dec 16, 2024 | Jan 14, 2025 | 29d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +19.1%S&P +38.9% · vs S&P 500 -19.8% | Jul 19, 2024 | Aug 15, 2024 | 27d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +28.1%S&P +39.0% · vs S&P 500 -10.9% | Jun 18, 2024 | Jul 9, 2024 | 21d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +1.5%S&P +75.0% · vs S&P 500 -73.5% | Oct 16, 2023 | Nov 11, 2023 | 26d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -13.0%S&P +71.5% · vs S&P 500 -84.5% | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -19.2%S&P +67.6% · vs S&P 500 -86.8% | Jul 19, 2023 | Aug 21, 2023 | 33d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -20.3%S&P +68.7% · vs S&P 500 -89.0% | Jul 20, 2023 | Aug 21, 2023 | 32d |
| Daniel S. Goldman | Stock | Sale | $50,001 - $100,000 | -12.7%S&P +73.5% · vs S&P 500 -86.2% | Jul 10, 2023 | Aug 13, 2023 | 34d |
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | -12.5%S&P +86.4% · vs S&P 500 -98.9% | Mar 31, 2023 | Apr 17, 2023 | 17d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
1 member · estimate, as of Sep 10, 20261 member reports a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded GMAB?
Alan Armstrong, Josh Gottheimer, Daniel S. Goldman disclosed GMAB transactions in the filings shown here.
Which members of Congress hold GMAB?
1 member of Congress reports a position in GMAB in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are GMAB trades disclosed?
Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.